AUTHOR=Xu Feng , Yu Piao , Wu Hongmei , Liu Mei , Liu Hongyun , Zeng Qian , Wu Dengli , Wang Xiangpei 

TITLE=Aqueous extract of Sargentodoxa cuneata alleviates ulcerative colitis and its associated liver injuries in mice through the modulation of intestinal flora and related metabolites

JOURNAL=Frontiers in Microbiology

VOLUME=15

YEAR=2024

URL=https://www.frontiersin.org/journals/microbiology/articles/10.3389/fmicb.2024.1295822

DOI=10.3389/fmicb.2024.1295822

ISSN=1664-302X

ABSTRACT=<sec id="sec1"><title>Background</title><p>Ulcerative colitis (UC) is a refractory disease worldwide. Liver injury can be found clinically with UC, and now, it is found that gut dysbiosis is an important mechanism in the pathogenesis of UC. <italic>Sargentodoxa cuneata</italic> has been used as a traditional Chinese medicine and is commonly used clinically for the treatment of UC. The main objective of this study was to investigate the intrinsic mechanisms of <italic>Sargentodoxa cuneata</italic> in the treatment of UC and its associated liver injuries from the perspective of intestinal flora and related metabolites.</p></sec><sec id="sec2"><title>Methods</title><p>Ultra-performance liquid chromatography-mass spectrometry was used to identify the components in the aqueous extract of <italic>Sargentodoxa cuneata</italic> (AESc). Mice with UC induced by dextran sulfate sodium were used to study the effects of AESc on UC and its associated liver injuries. Furthermore, 16S rRNA gene sequencing and analysis were performed on intestinal contents, and correlation analysis of intestinal flora with short-chain fatty acids (SCFAs) and organic acids was performed.</p></sec><sec id="sec3"><title>Results</title><p>A total of 114 compounds were identified in AESc. AESc improved disease activity index scores, liver index, and colon length in mice with UC and had a good protective effect on intestine and liver injuries. Moreover, the administration of AESc regulated gut microbiota dysbiosis and the levels of a few SCFAs and organic acids in mice with UC. In addition, the correlation analysis results showed that the <italic>Megamonas</italic> and <italic>Bifidobacterium</italic> were the key intestinal flora related to the levels of differential SCFAs and organic acids in mice with UC after AESc intervention.</p></sec><sec id="sec4"><title>Conclusion</title><p>AESc has a good protective effect on UC and UC related liver injuries. Modulation of the intestinal flora and its metabolites (SCFAs and a few organic acids) is an important pathway for AESc in the treatment of UC and also provides a rationale for the clinical use of <italic>Sargentodoxa cuneata</italic> in the treatment of UC.</p></sec>